SFM
SUPN icon

Systematic Financial Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Systematic Financial Management’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.1M Buy
474,131
+98,052
+26% +$4.71M 0.44% 87
2026
Q1 		$19.4M Buy
376,079
+71,853
+24% +$3.66M 0.45% 88
2025
Q4 		$15.1M Buy
304,226
+11,966
+4% +$582K 0.36% 109
2025
Q3 		$14M Buy
292,260
+46,715
+19% +$1.88M 0.34% 116
2025
Q2 		$7.74M Buy
245,545
+79,041
+47% +$2.53M 0.21% 135
2025
Q1 		$5.45M Buy
166,504
+53,004
+47% +$1.88M 0.16% 149
2024
Q4 		$4.1M Buy
113,500
+85,315
+303% +$3M 0.1% 159
2024
Q3 		$879K Buy
+28,185
New +$880K 0.02% 225
2020
Q3 		– Sell
-14,110
Closed -$335K – 425
2020
Q2 		$335K Sell
14,110
-7,470
-35% -$165K 0.02% 246
2020
Q1 		$388K Sell
21,580
-6,085
-22% -$128K 0.02% 230
2019
Q4 		$656K Buy
27,665
+9,280
+50% +$225K 0.03% 256
2019
Q3 		$505K Sell
18,385
-10,900
-37% -$323K 0.02% 397
2019
Q2 		$969K Buy
+29,285
New +$1M 0.04% 296

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Systematic Financial Management's SUPN Position: Q2 2026 in Review

Systematic Financial Management increased its Supernus Pharmaceuticals (SUPN) stake by 26% in Q2 2026, buying an estimated $4.71M and bringing the position to 474,131 shares worth $22.1M. The position accounts for 0.44% of the portfolio, ranked #87.

Systematic Financial Management first reported a position in SUPN in Q2 2019 and has held it in 13 quarters since. 334 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Systematic Financial Management held 474,131 shares of Supernus Pharmaceuticals worth $22.1M as of Q2 2026.
  • Systematic Financial Management bought 98,052 Supernus Pharmaceuticals shares in Q2 2026, an estimated $4.71M.
  • Supernus Pharmaceuticals made up 0.44% of Systematic Financial Management's portfolio in Q2 2026, its #87 holding.
  • Systematic Financial Management first reported a position in Supernus Pharmaceuticals in Q2 2019 and has held it in 13 quarters since.
  • 334 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Systematic Financial Management's 13F filing for Q2 2026, filed 14 Aug 2026.